ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.11 ($0.01) and traded as low as GBX 0.52 ($0.01). ValiRx shares last traded at GBX 0.54 ($0.01), with a volume of 2,136,314 shares.
ValiRx Price Performance
The company has a market capitalization of £2.03 million, a P/E ratio of -0.36 and a beta of 0.59. The stock’s fifty day simple moving average is GBX 0.67 and its 200-day simple moving average is GBX 1.11. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Canada Bond Market Holiday: How to Invest and Trade
- MarketBeat Week in Review – 03/24 – 03/28
- Top Biotech Stocks: Exploring Innovation Opportunities
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
